Evidence map›Paper›PMID 36407246›Full record

ReviewCureus2022

Does Vitamin D Have a Role in Diabetes?

Tahani M Abugoukh, Afrah Al Sharaby, Abeer O Elshaikh, Malaz Joda, Amna Madni, Ihab Ahmed, Rasha S Abdalla, Kholood Ahmed, Shahd E Elazrag, Nadir Abdelrahman

Open access · diamondAbstract readReview
In one paragraph

Review in Cureus, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 1 pooled it
3.1field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 1 synthesis or guideline pooled it, 21 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Tahani M AbugoukhInternal Medicine, Michigan State University College of Human Medicine, East Lansing, USA.
Afrah Al SharabyInternal Medicine, Michigan State University College of Human Medicine, East Lansing, USA.
Abeer O ElshaikhFamily Medicine - Geriatrics, Michigan State University College of Human Medicine, East Lansing, USA.
Malaz JodaFamily Medicine - Geriatrics, Michigan State University College of Human Medicine, East Lansing, USA.
Amna MadniInternal Medicine, Michigan State University College of Human Medicine, East Lansing, USA.
Ihab AhmedInternal Medicine, Michigan State University College of Human Medicine, East Lansing, USA.
Rasha S AbdallaInternal Medicine, Michigan State University College of Human Medicine, East Lansing, USA.
Kholood AhmedFamily Medicine - Geriatrics, Michigan State University College of Human Medicine, East Lansing, USA.
Shahd E ElazragInternal Medicine, Michigan State University College of Human Medicine, East Lansing, USA.
Nadir AbdelrahmanFamily Medicine - Geriatrics, Michigan State University College of Human Medicine, East Lansing, USA.
Michigan State University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Vitamin D, a fat-soluble vitamin, acts in the calcium and phosphorus metabolism in its active form (1,25-dihydroxy vitamin D). It may help prevent and treat autoimmune diseases, including diabetes mellitus. Diabetes has become a significant global health issue with a rising incidence and prevalence. A recent focus has been on vitamin D supplementation as part of efforts to discover novel ways to prevent and treat diabetes. Most evidence points to the vitamin D receptors (VDRS) gene in both types of diabetes. The main objective of this study is to analyze how vitamin D affects both type 1 and type 2 diabetes. In this literature review, we searched the PubMed and Google Scholar databases to collect related articles from 13 papers of different study designs. We found a significant association between vitamin D deficiency and type 1 and type 2 diabetes development. It has been shown that vitamin D supplements have a promising effect in reducing glycated hemoglobin (HbA1c) in patients with type 1 diabetes, with no significant impact on the incidence or improvement of type 2 diabetes. Patients with diabetes and people at high risk of diabetes need the appropriate amount of vitamin D; therefore, regular testing and vitamin D supplementation are advised for the management and prevention of diabetes. Additional randomized studies with bigger sample sizes and longer-term trials are required to fully explore the benefits of vitamin D supplementation in patients with type 1 and type 2 diabetes.

Indexed as

type 1 diabetestype 2 diabetesvitamin d and diabetesvitamin-d deficiencyvitamin d supplementation

Identifiers

PMID36407246
PMCPMC9671203
OpenAlexW4306742309

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.